Back to Research Hub
Roivant Sciences Ltd.
ROIV
$29.05+0.56 (+1.97%)
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis,…
StreetsValue research for Roivant Sciences Ltd. (ROIV)
Members get the full report for Roivant Sciences Ltd.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.